<VariationArchive RecordType="classified" VariationID="977496" VariationName="NM_006516.4(SLC2A1):c.293del (p.Met98fs)" VariationType="Deletion" Accession="VCV000977496" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-09-05" MostRecentSubmission="2020-09-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="965620" VariationID="977496">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.293del (p.Met98fs)</Name>
      <CanonicalSPDI>NC_000001.11:42930848:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42930849" stop="42930849" display_start="42930849" display_stop="42930849" variantLength="1" positionVCF="42930848" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43396520" stop="43396520" display_start="43396520" display_stop="43396520" variantLength="1" positionVCF="43396519" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>M98fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.33328del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43396520del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43396520del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42930849del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42930849del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.33328del">
            <Expression>NG_008232.1:g.33328del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.293del" MANESelect="true">
            <Expression>NM_006516.4:c.293del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Met98fs">
            <Expression>NP_006507.2:p.Met98fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.293delT" MANESelect="true">
            <Expression>NM_006516.4:c.293delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1643481831" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.293del (p.Met98fs) AND Childhood onset GLUT1 deficiency syndrome 2" Accession="RCV001255171" Version="1">
        <ClassifiedConditionList TraitSetID="5232">
          <ClassifiedCondition DB="MedGen" ID="C1842534">Childhood onset GLUT1 deficiency syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-09-05" MostRecentSubmission="2020-09-05">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10980529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31605543</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9462754</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1930" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Childhood onset GLUT1 deficiency syndrome 2</ElementValue>
                <XRef ID="MONDO:0012805" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 18</ElementValue>
                <XRef ID="Dystonia+18/2414" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exertion-induced dyskinesia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exercise-induced dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-SLC2A1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT18</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PED</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS2</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10541" />
                <XRef ID="10541" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="98811" DB="Orphanet" />
              <XRef ID="C1842534" DB="MedGen" />
              <XRef ID="MONDO:0012805" DB="MONDO" />
              <XRef Type="MIM" ID="612126" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2826974" SubmissionDate="2020-09-02" DateLastUpdated="2020-09-05" DateCreated="2020-09-05">
        <ClinVarSubmissionID localKey="NM_006516.4:c.293delT|OMIM:612126" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001431523" DateUpdated="2020-09-05" DateCreated="2020-09-05" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10980529</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31605543</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9462754</ID>
          </Citation>
          <Comment>This SLC2A1 variant is absent in a large population dataset and has not been reported in ClinVar nor the literature to our knowledge. This frameshift variant results in a premature stop codon, likely leading to nonsense-mediated decay and lack of protein production. We consider c.293delT to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.4:c.293delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612126" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8084590</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2826974" TraitType="Disease" MappingType="XRef" MappingValue="612126" MappingRef="OMIM">
        <MedGen CUI="C1842534" Name="Childhood onset GLUT1 deficiency syndrome 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

